Shengda Bio-pharm postponing the 2,000 t/a sucrose ferment project

On 23 June, Zhejiang Shengda Bio-pharm Co.,Ltd. (Shengda Bio-pharm) announced a deferment of the fund-raising 2,000 t/a sucrose ferment project whose completion is expected in June 2020, now extended to June 2022. According to the announcement, as th...

Sweeteners China News 202106

www.cnchemicals.com